Alternatives to Elman Bio

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

AI-guided drug discovery platform for tissue-targeted medicines.

Developing engineered biologics to harness the immune system for disease treatment.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Developing novel therapeutics by understanding the complex interplay of biological systems.

AI-powered drug discovery and development platform for biologics.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Develops and manufactures biologics for therapeutic applications.

Developing novel therapeutics for challenging diseases using advanced biological insights.

AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.

Biotech company focused on designing and developing novel biological solutions.

AI-powered platform for designing novel molecular structures for new medicines.

AI-powered platform for antibody discovery and development to create new medicines.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.